Chevy Chase Trust Portfolio holdings
AUM
$34.4B
This Quarter Return
-3.36%
1 Year Return
+23.59%
3 Year Return
+107.86%
5 Year Return
+189.12%
10 Year Return
+467.58%
AUM
$29B
AUM Growth
+$29B
(-6.5%)
Cap. Flow
-$231M
Cap. Flow
% of AUM
-0.8%
Top 10 Holdings %
Top 10 Hldgs %
29.36%
Holding
685
New
15
Increased
348
Reduced
238
Closed
42
Top Buys
| 1 |
Shell
SHEL
|
$117M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
$39.4M |
| 3 |
Franco-Nevada
FNV
|
$31.4M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
$30.6M |
| 5 |
Advanced Micro Devices
AMD
|
$28.4M |
Top Sells
| 1 |
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
|
$90.9M |
| 2 |
NVIDIA
NVDA
|
$51.9M |
| 3 |
Apple
AAPL
|
$38.1M |
| 4 |
Guardant Health
GH
|
$36M |
| 5 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
$31.8M |
Sector Composition
| 1 | Technology | 26.61% |
| 2 | Healthcare | 13.64% |
| 3 | Financials | 12.99% |
| 4 | Consumer Discretionary | 10.62% |
| 5 | Communication Services | 9.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Chevron
CVX
$318B
| $193M | 0.67% |
1,186,399
+325
| +0% | +$52.9K |
|
27
Pfizer
PFE
$141B
| $179M | 0.62% |
3,466,119
+8,620
| +0.2% | +$446K |
|
28
AbbVie
ABBV
$374B
| $179M | 0.62% |
1,106,874
+1,155
| +0.1% | +$187K |
|
29
Bank of America
BAC
$371B
| $178M | 0.61% |
4,329,133
-45,056
| -1% | -$1.86M |
|
30
Regeneron Pharmaceuticals
REGN
$59.8B
| $175M | 0.6% |
250,035
+18,161
| +8% | +$12.7M |
|
31
Intuitive Surgical
ISRG
$158B
| $171M | 0.59% |
567,476
-5,545
| -1% | -$1.67M |
|
32
Illumina
ILMN
$15.2B
| $169M | 0.58% |
484,705
-24,414
| -5% | -$8.53M |
|
33
Estee Lauder
EL
$33.1B
| $161M | 0.56% |
593,048
-73,524
| -11% | -$20M |
|
34
Broadcom
AVGO
$1.42T
| $157M | 0.54% |
249,702
+1,381
| +0.6% | +$870K |
|
35
EOG Resources
EOG
$65.8B
| $156M | 0.54% |
1,306,511
-40,980
| -3% | -$4.89M |
|
36
Coca-Cola
KO
$297B
| $153M | 0.53% |
2,473,609
+3,648
| +0.1% | +$226K |
|
37
Cisco
CSCO
$268B
| $148M | 0.51% |
2,659,856
+6,599
| +0.2% | +$368K |
|
38
Thermo Fisher Scientific
TMO
$183B
| $141M | 0.49% |
239,374
+381
| +0.2% | +$225K |
|
39
Danaher
DHR
$143B
| $141M | 0.49% |
480,152
-8,635
| -2% | -$2.53M |
|
40
Eli Lilly
LLY
$661B
| $138M | 0.48% |
483,286
+1,241
| +0.3% | +$355K |
|
41
Target
TGT
$42B
| $137M | 0.47% |
645,265
+67,117
| +12% | +$14.2M |
|
42
CVS Health
CVS
$93B
| $136M | 0.47% |
1,338,986
+28,785
| +2% | +$2.91M |
|
43
Schlumberger
SLB
$52.2B
| $132M | 0.46% |
3,196,755
+21,765
| +0.7% | +$899K |
|
44
Abbott
ABT
$230B
| $132M | 0.45% |
1,112,265
+1,157
| +0.1% | +$137K |
|
45
Adobe
ADBE
$148B
| $130M | 0.45% |
285,919
-2,469
| -0.9% | -$1.12M |
|
46
Merck
MRK
$210B
| $130M | 0.45% |
1,583,051
+1,933
| +0.1% | +$159K |
|
47
Intel
INTC
$105B
| $129M | 0.44% |
2,603,444
+5,691
| +0.2% | +$282K |
|
48
Comcast
CMCSA
$125B
| $129M | 0.44% |
2,746,482
-17,079
| -0.6% | -$800K |
|
49
Walmart
WMT
$793B
| $128M | 0.44% |
857,097
-3,833
| -0.4% | -$571K |
|
50
Salesforce
CRM
$245B
| $126M | 0.44% |
594,991
+5,393
| +0.9% | +$1.15M |
|